ICLR ICON PLC

$190.43

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/6/2025

About ICON PLC

ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe, the United States and internationally. The company is headquartered in Dublin, Ireland.

Website: https://www.iconplc.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1060955
Address
SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN, DUBLIN 18, IE
Valuation
Market Cap
$11.26B
P/E Ratio
14.62
PEG Ratio
0.63
Price to Book
1.18
Performance
EPS
$9.53
Dividend Yield
Profit Margin
9.56%
ROE
8.44%
Technicals
50D MA
$177.50
200D MA
$242.02
52W High
$347.72
52W Low
$137.87
Fundamentals
Shares Outstanding
81M
Target Price
$213.62
Beta
1.24

ICLR EPS Estimates vs Actual

Estimated
Actual

ICLR News & Sentiment

Sep 04, 2025 • Benzinga NEUTRAL
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports
Paul Brunetta, M.D., joins as Chief Medical Officer; Kristen Quigley joins as Chief Clinical Operations Officer; Alpana Naresh, Ph.D., joins as Vice President and Head, CMC Strategy and Manufacturing
Sep 03, 2025 • Benzinga SOMEWHAT-BULLISH
Comscore Debuts AI-Powered Data Partner Network to Transform Audience Insights Data at Scale - comScore ( NASDAQ:SCOR )
RESTON, Va., Sept. 03, 2025 ( GLOBE NEWSWIRE ) -- Comscore, a global leader in measuring and analyzing consumer behaviors, today announced the launch of its AI-powered Data Partner Network, a new initiative that enables third-party data providers to convert their ID-based datasets into scalable, ...
Sep 03, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Comscore Debuts AI-Powered Data Partner Network to Transform Audience Insights Data at Scale
Proprietary AI Predictive Technology Generates ID-Free Audience Segments That Can Be Activated In Programmatic Environments Proprietary AI Predictive Technology Generates ID-Free Audience Segments That Can Be Activated In Programmatic Environments ...
Aug 22, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors
SAN DIEGO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) ( Nasdaq: GYRE ) , an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, ...
Aug 22, 2025 • Benzinga SOMEWHAT-BULLISH
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors - Gyre Therapeutics ( NASDAQ:GYRE )
SAN DIEGO, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Gyre Therapeutics ( "Gyre" ) GYRE, an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced the appointment of Dan Weng, M.D., to its ...
Jul 27, 2025 • Benzinga BULLISH
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week ( July 21-July 25 ) : Are The Others In Your Portfolio? - Astera Labs ( NASDAQ:ALAB ) , Baker Hughes ( NASDAQ:BKR )
Medpace surged over 137% after crushing Q2 earnings estimates. Strong earnings and raised guidance drove sharp gains in pharma and tech names. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily. These ten large-cap stocks were top performers last week.
Sentiment Snapshot

Average Sentiment Score:

0.105
50 articles with scored sentiment

Overall Sentiment:

Neutral

ICLR Reported Earnings

Apr 22, 2025
Mar 31, 2025 (Pre market)
-0.21 Surprise
  • Reported EPS: $3.19
  • Estimate: $3.40
  • Whisper:
  • Surprise %: -6.2%
Feb 19, 2025
Dec 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $3.43
  • Estimate: $3.43
  • Whisper:
  • Surprise %: 0.1%
Oct 23, 2024
Sep 30, 2024 (Post market)
-0.49 Surprise
  • Reported EPS: $3.35
  • Estimate: $3.84
  • Whisper:
  • Surprise %: -12.8%
Jul 24, 2024
Jun 30, 2024 (Post market)
0.07 Surprise
  • Reported EPS: $3.75
  • Estimate: $3.68
  • Whisper:
  • Surprise %: 1.9%
Apr 24, 2024
Mar 31, 2024 (Post market)
0.06 Surprise
  • Reported EPS: $3.47
  • Estimate: $3.41
  • Whisper:
  • Surprise %: 1.8%
Mar 12, 2024
Dec 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $3.46
  • Estimate: $3.44
  • Whisper:
  • Surprise %: 0.6%
Oct 25, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $3.30
  • Estimate: $3.28
  • Whisper:
  • Surprise %: 0.6%
Jul 26, 2023
Jun 30, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $3.11
  • Estimate: $3.08
  • Whisper:
  • Surprise %: 1.0%
Apr 26, 2023
Mar 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $2.90
  • Estimate: $2.88
  • Whisper:
  • Surprise %: 0.7%

Financials